FDA.reportPublic FDA data

Rivfloza 80 MG per 0.5 ML Injection

RxCUI
2675309
RxNorm name
Rivfloza 80 MG per 0.5 ML Injection
Display name
Rivfloza 80 MG per 0.5 ML Injection
Full name
Rivfloza 80 MG per 0.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIVFLOZANEDOSIRANNovo Nordiskace9d4bc-4d20-4beb-9e9d-8886904248332025-03-03Adverse reactionsExact identifier
rxcui: 2675309

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ace9d4bc-4d20-4beb-9e9d-888690424833rivfloza 80 MG in 0.5 ML Injection [PSN] · 0.5 ML nedosiran 160 MG/ML Injection [Rivfloza] [SBD] · 0.5 ML Rivfloza 160 MG/ML Injection [SY] · Rivfloza 80 MG per 0.5 ML Injection [SY]44These highlights do not include all the information needed to use RIVFLOZA safely and effectively. See full prescribing information for RIVFLOZA. RIVFLOZA ® (nedosiran) injection, for subcutaneous use Initial U.S. Approval: 202320250303